Research Topics
Species | M EmreSummaryAffiliation: Istanbul University Country: Turkey Publications
| Collaborators
|
Detail Information
Publications
Dementia in Parkinson's disease: cause and treatmentMurat Emre
Istanbul Faculty of Medicine, Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Capa Istanbul, Turkey
Curr Opin Neurol 17:399-404. 2004..The purpose of this article is to provide an overview of recent findings on dementia associated with Parkinson's disease, from February 2003 to the present...
Rivastigmine in dementia associated with Parkinson's disease and Alzheimer's disease: similarities and differencesMurat Emre
Department of Neurology, Istanbul Faculty of Medicine, Istanbul, Turkey
J Alzheimers Dis 11:509-19. 2007..In both populations, hallucinations may identify patients who are likely to be more treatment-responsive...
Evidence-based pharmacological treatment of dementiaM Emre
Department of Neurology, Istanbul Medical School, University of Istanbul, Turkey
Eur J Neurol 7:247-53. 2000..The evidence for efficacy, however, is not strong for the majority of these compounds...
Clinical diagnostic criteria for dementia associated with Parkinson's diseaseMurat Emre
Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
Mov Disord 22:1689-707; quiz 1837. 2007..Based on the characteristic features associated with this condition, clinical diagnostic criteria for probable and possible PD-D are proposed...
Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trialMurat Emre
Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey
Lancet Neurol 9:969-77. 2010..Therefore, the efficacy and safety of memantine were investigated in patients with mild to moderate Parkinson's disease dementia (PDD) or dementia with Lewy bodies (DLB)...
Rivastigmine for dementia associated with Parkinson's diseaseMurat Emre
Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
N Engl J Med 351:2509-18. 2004..Cholinergic deficits are prominent in patients who have dementia associated with Parkinson's disease. We investigated the effects of the dual cholinesterase inhibitor rivastigmine in such patients...
Treatment of dementia associated with Parkinson's diseaseM Emre
Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
Parkinsonism Relat Disord 13:S457-61. 2007..Based on a large, randomized, placebo controlled trial, the ChE-I rivastigmine has been approved for the treatment of dementia associated with PD...
Pooled analyses on cognitive effects of memantine in patients with moderate to severe Alzheimer's diseaseMurat Emre
Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
J Alzheimers Dis 14:193-9. 2008..It is concluded that treatment with memantine provides benefits in all three cognitive functions...
Classification and diagnosis of dementia: a mechanism-based approachM Emre
Department of Neurology, Istanbul Faculty of Medicine, Capa Istanbul, Turkey
Eur J Neurol 16:168-73. 2009..This article is an attempt to provide a comprehensive, yet simplified classification of dementias following a mechanism-based approach. A systematic approach to diagnostic work-up is also proposed based on this classification...
What causes mental dysfunction in Parkinson's disease?Murat Emre
Istanbul Faculty of Medicine, Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Istanbul University, Capa Istanbul, Turkey
Mov Disord 18:S63-71. 2003....
Dementia associated with Parkinson's diseaseMurat Emre
Department of Neurology, Istanbul Faculty of Medicine, Istanbul, Turkey
Lancet Neurol 2:229-37. 2003..Alzheimer's disease-type pathology is commonly associated with dementia but less predictive. Recent evidence from small studies suggests that cholinesterase inhibitors may be effective in the treatment of dementia associated with PD...
Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer diseaseMurat Emre
Department of Neurology, Behavioural Neurology and Movement Disorders Unit, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
CNS Neurosci Ther 16:246-53. 2010..Rivastigmine patch provides an efficient option for managing patients with AD, to be considered among the first line therapies for the disease...
Experimental approaches and drugs in development for the treatment of dementiaM Emre
Istanbul Medical School, Department of Neirology, Capa Istanbul, Turkey
Expert Opin Investig Drugs 10:607-17. 2001..Likewise, recent studies suggest that some statins may have a prophylactic effect...
The combinations of TNFalpha-308 and IL-6 -174 or IL-10 -1082 genes polymorphisms suggest an association with susceptibility to sporadic late-onset Alzheimer's diseaseP Vural
Department of Biochemistry, Istanbul Faculty of Medicine, Istanbul University, Capa, 34093, Istanbul, Turkey
Acta Neurol Scand 120:396-401. 2009....
The prevalence of dementia in an urban Turkish populationH Gurvit
Behavioral Neurology and Movement Disorders Unit, Department of Neurology, Faculty of Medicine, Istanbul University, Capa, Istanbul, Turkey
Am J Alzheimers Dis Other Demen 23:67-76. 2008..0% (95% CI, 7.0% to 15.0%) and 20.0% (95% CI, 14.0% to 26.0%), respectively, in this population. Prevalence rates of dementia and AD in Istanbul, Turkey, are comparable with those seen in the Western world...
Do unilateral ablative lesions of the subthalamic nucleu in parkinsonian patients lead to hemiballism?O Barlas
Department of Neurosurgery, Istanbul Faculty of Medicine, University of Istanbul, Capa Istanbul, Turkey
Mov Disord 16:306-10. 2001..We conclude that hemiballism following unilateral ablation of STN in patients with PD is a rare phenomenon, and unilateral ablative lesions of STN can be performed safely...
Treatment of behavioural symptoms and dementia in Parkinson's diseaseHasmet A Hanagasi
Behavioral Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, 34390 Capa Istanbul, Turkey
Fundam Clin Pharmacol 19:133-46. 2005..Recent evidence from small double-blind and open-label trials suggests that cholinesterase inhibitors may be effective in the treatment of dementia associated with PD...
Stiff leg syndrome: case reportM E Gurol
Department of Neurology, Istanbul School of Medicine, University of Istanbul, Istanbul, Turkey
Mov Disord 16:1189-93. 2001..She improved substantially with clonazepam 4 mg/day. She presented with electrophysiological findings not previously reported in stiff leg syndrome, which may suggest increased inhibition in the uninvolved upper extremities...
The Arg194Trp polymorphism in DNA repair gene XRCC1 and the risk for sporadic late-onset Alzheimer's diseaseS Dogru-Abbasoglu
Department of Biochemistry, Istanbul University, Capa 34093, Istanbul, Turkey
Neurol Sci 28:31-4. 2007..In addition, the 194Trp allele revealed a borderline significance (OR=2.05, 95% CI 0.96-4.37, p=0.056). According to our results, it may be speculated that the polymorphic variants of XRCC1 codon 194 have a role in the development of AD...
Atypical neurological involvement associated with celiac diseaseH A Hanagasi
Department of Neurology, Behavioural Neurology and Movement Disorders Unit, Istanbul Medical School, Istanbul University, Istanbul, Turkey
Eur J Neurol 8:67-9. 2001..We suggest that celiac disease can present with a variety of unusual neurological manifestations...
Cognitive impairment in amyotrophic lateral sclerosis: evidence from neuropsychological investigation and event-related potentialsHasmet A Hanagasi
University of Istanbul, Istanbul Medical School, Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Istanbul, Turkey
Brain Res Cogn Brain Res 14:234-44. 2002..These results indicate subclinical impairment of cognitive functions in patients with ALS. The pattern of cognitive impairment suggests the dysfunction of the frontal network...
The distribution pattern of pathology and cholinergic deficits in amygdaloid complex in Alzheimer's disease and dementia with Lewy bodiesHuseyin A Sahin
Department of Neurology, Ondokuz Mayis University, Faculty of Medicine, Kurupelit, 55139, Samsun, Turkey
Acta Neuropathol 111:115-25. 2006....
Parkin expression in muscle from three patients with autosomal recessive Parkinson's disease carrying parkin mutationP Serdaroglu
Department of Neurology, Faculty of Medicine, Istanbul University, Istanbul, Turkey
Acta Myol 24:2-5. 2005..Further investigation of parkin expression in skeletal muscle is warranted...
The attitude of elderly lay people towards the symptoms of dementiaHuseyin A Sahin
Ondokuz Mayis University, Faculty of Medicine, Department of Neurology, Kurupelit, Samsun, Turkey
Int Psychogeriatr 18:251-8. 2006..To assess the attitude of elderly lay people towards the concept and symptoms of dementia...
Association between vitamin D receptor gene polymorphism and Alzheimer's diseaseDuygu Gezen-Ak
Istanbul University, Cerrahpasa Faculty of Medicine, Department of Medical Biology, Istanbul, Turkey
Tohoku J Exp Med 212:275-82. 2007..006) indicating a protective role of the "AT" haplotype in AD. Consequently, this study provides evidence for a possible link between AD and vitamin D...
Clozapine treatment in oromandibular dystoniaHasmet A Hanagasi
Istanbul University, Istanbul Faculty of Medicine, Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Istanbul, Turkey
Clin Neuropharmacol 27:84-6. 2004..We suggest that clozapine should be considered in patients with OMD who fail to response to other treatments...
Clinical and magnetic resonance imaging findings of HIV-negative patients with neurosyphilisCandan Gurses
Department of Neurology, Faculty of Medicine, University of Istanbul, 34390, Capa, Istanbul, Turkey
J Neurol 254:368-74. 2007..This finding may be due to cytotoxic edema associated with status epilepticus and may mimic herpes simplex and other limbic encephalitides. Though not typical, certain MRI findings guides for the diagnosis of neurosyphilis...
Presenilin-1 gene intronic polymorphism and late-onset Alzheimer's diseaseErdinç Dursun
Department of Medical Biology, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey
J Geriatr Psychiatry Neurol 21:268-73. 2008..52, P = .32, respectively), when the control and patients were compared. Consequently, our results showed that the 1/1 genotype does not increase the risk of developing late-onset Alzheimer's disease in the Turkish population...
Risk factors for Alzheimer disease: a population-based case-control study in Istanbul, TurkeyHande Harmanci
Department of Public Health, Marmara University Medical Faculty, Istanbul University, Istanbul Medical Faculty, Istanbul, Turkey
Alzheimer Dis Assoc Disord 17:139-45. 2003..77, 95% CI = 1.12-6.85). Our results suggest that having a higher education is protective from AD and that electromagnetic field exposure at work or at home is a significant risk factor...
Interleukin-1alpha -889 C/T polymorphism in Turkish patients with late-onset Alzheimer's diseaseErdinç Dursun
Department of Medical Biology, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey
Dement Geriatr Cogn Disord 27:82-7. 2009..The aim of the current study is to determine whether there is an association between the promoter region polymorphism of the interleukin-1alpha gene and late-onset AD in a cohort of Turkish patients...
Mitochondrial complex I, II/III, and IV activities in familial and sporadic Parkinson's diseaseHasmet Ayhan Hanagasi
Istanbul University, Istanbul Faculty of Medicine, Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Istanbul, Turkey
Int J Neurosci 115:479-93. 2005..In this study, the data indicate no significant differences in mitochondrial complex I-IV activities in PDF and PDS...
Single nucleotide polymorphisms in base-excision repair genes hOGG1, APE1 and XRCC1 do not alter risk of Alzheimer's diseaseHande Parildar-Karpuzoglu
Department of Biochemistry, Istanbul Medical Faculty, Istanbul University, Capa, Istanbul, Turkey
Neurosci Lett 442:287-91. 2008..08, 95% CI=0.70-1.68), XRCC1-Arg280His (OR=0.53, 95% CI=0.24-1.14) and XRCC1-Arg399Gln (OR=1.05, 95% CI=0.68-1.63) and AD. Our results suggest that the polymorphic variants of these BER genes are not independent risk factors for AD...
Unrecognized depression in community-dwelling elderly persons in IstanbulIsin Baral Kulaksizoglu
Istanbul University, Istanbul Faculty of Medicine, Department of Psychiatry, Capa 34390
Int Psychogeriatr 17:303-12. 2005..Most studies of old age depression have been conducted in developed countries. The present study was conducted to determine the prevalence of depressive disorders among Turkish elderly in an urban community...
Polymorphisms in the DNA repair genes XPD (ERCC2) and XPF (ERCC4) are not associated with sporadic late-onset Alzheimer's diseaseSemra Dogru-Abbasoglu
Department of Biochemistry, Istanbul Medical Faculty, Istanbul University, Capa, Istanbul, Turkey
Neurosci Lett 404:258-61. 2006..94, 95% CI=0.63-1.41), XPD/exon 23 (OR=1.24, 95% CI=0.82-1.86) and XPF/exon 11 (OR=1.08, 95% CI=0.72-1.64) and AD. Our results suggest that the polymorphic variants of these NER genes do not contribute to the risk of developing AD...
Comparative analysis of event-related potentials during Go/NoGo and CPT: decomposition of electrophysiological markers of response inhibition and sustained attentionElif Kirmizi-Alsan
Department of Physiology, Istanbul Faculty of Medicine, Istanbul University, , Fizyoloji Anabilim Dali, 34390 Capa-Istanbul, Turkey
Brain Res 1104:114-28. 2006..The latency prolongation observed with the NoGo condition of the CPT paradigm was thought to be due to perseverance/inhibition conflict enhanced by the primer stimuli in CPT...
Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension studyWerner Poewe
Innsbruck Medical University, Innsbruck, Austria
Mov Disord 21:456-61. 2006..Long-term rivastigmine treatment appeared well tolerated and may provide sustained benefits in dementia associated with PD patients who remain on treatment for up to 48 weeks...
Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's diseaseDavid Burn
Regional Neuroscience Center, Newcastle General Hospital, Newcastle upon Tyne, United Kingdom
Mov Disord 21:1899-907. 2006..Visual hallucinations appear to predict more rapid decline and possibly greater therapeutic benefit from rivastigmine treatment in PDD...
Characterizing clinical phenotypes: the Lewys in their life or the life of their Lewys?Carol F Lippa
Neurology 67:1910-1. 2006
Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitorsSerge Gauthier
McGill Centre for Studies in Aging, Verdun, Quebec, Canada
Curr Med Res Opin 19:707-14. 2003..The panel also aimed to reach consensus on 'whom to switch', 'when to switch' and 'how to switch'. The key findings from that meeting are reported in this review...
Subthreshold depression in patients with Parkinson's disease and dementia--clinical and demographic correlatesUwe Ehrt
Norwegian Centre for Movement Disorders, Stavanger University Hospital, Norway
Int J Geriatr Psychiatry 22:980-5. 2007....
Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's diseaseKolbjorn Bronnick
Norwegian Centre for Movement Disorders, Stavanger University Hospital, Helse Stavanger, Norway
J Neurol Neurosurg Psychiatry 78:1064-8. 2007..To compare the profile of cognitive impairment in Alzheimer's disease (AD) with dementia associated with Parkinson's disease (PDD)...
Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task forceBruno Dubois
INSERM UPMC UMRS 610, Federation of Neurology, AP HP, Salpêtrière Hospital Université Paris6, Paris, France
Mov Disord 22:2314-24. 2007..We accept, however, that further validation of certain tests and modifications in the recommended cut off values will be required through future studies...
Effects of rivastigmine on tremor and other motor symptoms in patients with Parkinson's disease dementia: a retrospective analysis of a double-blind trial and an open-label extensionWolfgang Oertel
Department of Neurology, Philipps University, Marburg, Germany
Drug Saf 31:79-94. 2008..The current analyses were performed to examine the potential of rivastigmine to affect tremor and other motor symptoms in patients with PDD...
Changes in motor subtype and risk for incident dementia in Parkinson's diseaseGuido Alves
The Norwegian Center for Movement Disorders, Stavanger, Norway
Mov Disord 21:1123-30. 2006..These findings raise the question whether PIGD and dementia share common or parallel neuropathology...
The 2nd International Symposium on Alzheimer's disease and related disorders in the Middle East, May 1-3, 2003, Istanbul, TurkeyChangiz Geula
Laboratory for Neurodegenerative and Aging Research, Department of Medicine, Harvard Medical School, Boston, MA 02215, USA
Amyloid 11:276-80. 2004
Efficacy and safety of levodopa with entacapone in Parkinson's disease patients suboptimally controlled with levodopa alone, in daily clinical practice: an international, multicentre, open-label studyOscar Gershanik
Hospital Frances La Rioja 951, Buenos Aires, Argentina
Prog Neuropsychopharmacol Biol Psychiatry 27:963-71. 2003....
The 3rd International Symposium on Alzheimer's Disease and Related Disorders in the Middle East, Istanbul, Turkey, October 1 - 2, 2005Robert P Friedland
Department of Neurology, Case School of Medicine, Cleveland, OH 44106, USA
Amyloid 14:161-8. 2007
